Growth Metrics

Novartis Ag (NVS) Cash from Discontinued Operations (2018 - 2023)

Novartis Ag's Cash from Discontinued Operations history spans 6 years, with the latest figure at 164000000.0 for Q4 2023.

  • On a quarterly basis, Cash from Discontinued Operations fell 52.19% to 164000000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was 402000000.0, a 49.05% decrease, with the full-year FY2023 number at 238000000.0, down 80.12% from a year prior.
  • Cash from Discontinued Operations hit 164000000.0 in Q4 2023 for Novartis Ag, up from 74000000.0 in the prior quarter.
  • Over the last five years, Cash from Discontinued Operations for NVS hit a ceiling of 499000000.0 in Q2 2019 and a floor of 59000000.0 in Q2 2023.
  • Historically, Cash from Discontinued Operations has averaged 221000000.0 across 3 years, with a median of 134500000.0 in 2023.
  • Biggest five-year swings in Cash from Discontinued Operations: increased 16.05% in 2019 and later plummeted 83.41% in 2023.
  • Tracing NVS's Cash from Discontinued Operations over 3 years: stood at 499000000.0 in 2019, then plummeted by 31.26% to 343000000.0 in 2022, then tumbled by 52.19% to 164000000.0 in 2023.
  • Business Quant data shows Cash from Discontinued Operations for NVS at 164000000.0 in Q4 2023, 74000000.0 in Q3 2023, and 59000000.0 in Q2 2023.